// App-Quantinova.ai

e12516 : Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis.

Researchers

Presenter

  • Luca Moscetti

Principal Investigators

  • Claudia Omarini

  • Isabella Sperduti

  • Fabio Canino

  • Monica Barbolini

  • Cecilia Nasso

  • Angela Toss

  • Massimo Dominici

  • Federico Piacentini

Medical Centers

  • University Hospital of Siena, Siena, Italy

  • Regina Elena National Cancer Institute IRCCS, Biostatistics, Rome, Italy

  • Univeristy of Modena and Reggio Emilia, Modena, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Oncology (ONC)

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Breast cancer

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Abemaciclib

  • Tamoxifen

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved